Study Explores Rosemary Compound’s Role in Anti-Inflammatory Drug Development for Alzheimer’s Disease

Researchers are investigating carnosic acid, a compound found in rosemary and sage, for its potential impact on Alzheimer’s disease. The study focuses on the compound’s anti-inflammatory properties, which may address one of the key factors contributing to cognitive decline in individuals with the disease. Alzheimer’s is currently the leading cause of dementia and ranks as the sixth leading cause of death in the United States.

Inflammation has been identified as a significant component in Alzheimer’s progression, prompting scientists to explore compounds that could mitigate its effects. Carnosic acid, naturally occurring in common herbs like rosemary and sage, has drawn attention due to its association with memory enhancement and neuroprotective qualities. Researchers aim to determine whether this compound can be utilized in developing treatments that target inflammation-related pathways in Alzheimer’s patients. Further studies are expected to assess its efficacy and potential applications within pharmaceutical contexts.

Date: March, 2025

Newsflash | Powered by GeneOnline AI

Related posts:

Alzheimer’s Research: 16 New Susceptibility Genes Identified Study Links Antidepressants to Accelerated Cognitive Decline in Dementia Patients Stanford Study Reveals Brain’s ‘Sugar Shield’ as a Potential Key to Understanding Aging Study Links Poor Sleep in Older Adults to Glymphatic System Disruption

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後